Kish Kapoor
President, Wellington West Holdings Inc.

Kish joined Wellington West as President of Wellington West Holdings Inc. in January 2007. Since that time, he has led the company through transformational change. Kish is responsible for defining and executing the corporate strategy that is creating a stronger, more client-focused and more profitable company that is focused on simplifying processes, personalizing service and creating a fun working environment. Under Kish’s guidance, Wellington West is planning its transition from private ownership to a public company.

Prior to joining Wellington West, Kish served for two years as Executive Vice-President, Corporate Development of Loring Ward International Ltd., which was formed to hold the U.S. operations of Assante Corporation.

As one of the founders of Assante, Kish was Executive Vice-President, Corporate Development, from 1994 to 2003, where he was instrumental in the development and execution of their corporate strategy. This included 26 acquisitions, including eight in the U.S. During this time, Assante grew to over 1,500 financial advisors, and assets increased from $200 million to over $20 billion, including over $11 billion in their North American wealth management offering. In 1999, Kish played an important role in taking Assante public, and spearheaded the nearly $900 million transaction, which led to the sale of their Canadian operations in 2003 to CI Financial.

Previously, Kish was a tax partner with KPMG LLP. During his 14 years with KPMG, he specialized in offering clients advice on tax, corporate finance, mergers and acquisitions, and development of corporate strategy in a wide range of industries, including those in the biotechnology sector.

Kish is presently the Chair of the Strategic Planning Committee and a member of the Audit Committee of the Board of Directors of Manitoba Telecom Services Inc., a public company listed on the Toronto Stock Exchange (TSX), and the Chair of the Audit Committee of the Board of Directors of Medicure, a biopharmaceutical company also listed on the TSX.